Stocks With The Most
Fund Call Options
| Name | Net Calls | Calls | Puts |
Return since 30 Sep ‘14 |
|
|---|---|---|---|---|---|
| $181M | $218M | $37.3M | 60.9% |
|
|
| $97.1M | $146M | $49.2M | 81% |
|
|
| $73.5M | $212M | $139M | 89.3% |
|
|
4
Sarepta Therapeutics
SRPT
$1.66B
| $65.4M | $102M | $37M | 24.8% |
|
| $65.2M | $104M | $38.5M | 60.8% |
|
|
| $59.7M | $163M | $103M | 50.1% |
|
|
| $59.6M | $103M | $43.6M | 97.2% |
|
|
| $57.5M | $62.1M | $4.59M | 86.6% |
|
|
| $57M | $83.8M | $26.8M | 92.4% |
|
|
| $56.5M | $122M | $65.6M | 93.3% |
|
|
11
Pitney Bowes
PBI
$1.7B
| $53.3M | $95.4M | $42.1M | 57.7% |
|
| $51.9M | $59.1M | $7.22M | 73.3% |
|
|
| $51.7M | $323M | $272M | 89.1% |
|
|
| $46.2M | $54.1M | $7.88M | 64% |
|
|
| $41.1M | $65.8M | $24.7M | 91.9% |
|
|
| $38.8M | $90.9M | $52.1M | 32.3% |
|
|
| $35.5M | $39.3M | $3.78M | 76.1% |
|
|
| $30.3M | $43.2M | $12.8M | 99.7% |
|
|
| $27.3M | $52.6M | $25.3M | 28% |
|
|
| $24.6M | $35.8M | $11.2M | 99.4% |
|
|
| $23.4M | $39.6M | $16.2M | 51.8% |
|
|
| $22.8M | $41.1M | $18.4M | 74.7% |
|
|
| $22.4M | $176M | $154M | 92.4% |
|
|
| $22.1M | $55M | $32.8M | 78.3% |
|
|
| $16.7M | $27.4M | $10.8M | 70.2% |
|